<mets:mets xmlns:mets="http://www.loc.gov/METS/" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink">
    <mets:dmdSec ID="DMD_biejournals_4619">
        <mets:mdWrap MIMETYPE="text/xml" MDTYPE="MODS">
            <mets:xmlData>
                <mods xmlns="http://www.loc.gov/mods/v3" version="3.7" xmlns:vl="http://visuallibrary.net/vl">
                    <titleInfo lang="ger">
                        <nonSort>Das </nonSort>
                        <title>Potenzial der mRNA-Technologie</title>
                        <subTitle>Der Weg des Biotechnologieunternehmens CureVac</subTitle>
                    </titleInfo>
                    <titleInfo type="translated">
                        <nonSort>The </nonSort>
                        <title>potential of mRNA technology</title>
                    </titleInfo>
                    <name type="personal">
                        <displayForm>Giesler, Simone</displayForm>
                        <namePart type="family">Giesler</namePart>
                        <namePart type="given">Simone</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">ctb</roleTerm>
                        </role>
                    </name>
                    <typeOfResource>text</typeOfResource>
                    <genre authority="dini">article</genre>
                    <originInfo>
                        <dateIssued encoding="w3cdtf" keyDate="yes">2021-08-09</dateIssued>
                    </originInfo>
                    <physicalDescription>
                        <extent unit="page">7</extent>
                    </physicalDescription>
                    <abstract lang="ger">Die mRNA-Technologie lässt eine neue Produktklasse in der Medizin entstehen, mit der gegen Infektionserkrankungen prophylaktisch und gegen viele Krebsarten therapeutisch geimpft werden kann sowie seltene Krankheiten bekämpft werden können.</abstract>
                    <abstract lang="eng">mRNA technology is giving rise to a novel class of medical products that can be used to prophylactically vaccinate against infectious diseases and therapeutically vaccinate against many types of cancer, as well as to combat rare diseases.</abstract>
                    <recordInfo>
                        <recordIdentifier>biejournals_4619</recordIdentifier>
                    </recordInfo>
                </mods>
            </mets:xmlData>
        </mets:mdWrap>
    </mets:dmdSec>
    <mets:fileSec>
        <mets:fileGrp USE="pdf upload">
            <mets:file MIMETYPE="application/pdf" ID="FILE0_biejournals_4619">
                <mets:FLocat xlink:href="https://www.biuz.de/index.php/biuz/article/download/4619/4387" LOCTYPE="URL"/>
            </mets:file>
        </mets:fileGrp>
    </mets:fileSec>
    <mets:structMap TYPE="LOGICAL">
        <mets:div TYPE="document" ID="biejournals_4619" DMDID="DMD_biejournals_4619">
            <mets:fptr FILEID="FILE0_biejournals_4619"/>
        </mets:div>
    </mets:structMap>
</mets:mets>
